Homocysteine and cardiovascular risk;Homocystein und kardiovaskuläres risiko

Wiener Medizinische Wochenschrift

Volumn 151, Issue 1-2, 2001, Pages 25-28

  Auer, J ^a   Berent, R ^a   Weber, T ^a   Lassnig E ^a   Eber, B ^a  

^a II Interne Abteilung   (Austria)

Author keywords

Cardiovascular risk factors; Folic acid; Homocysteine; Vitamin B12

Indexed keywords

AMINO ACID; ANDROGEN; CARBAMAZEPINE; COLESTIPOL; COLESTYRAMINE; CYANOCOBALAMIN; CYCLOSPORIN A; FOLIC ACID; HOMOCYSTEINE; METFORMIN; METHIONINE; METHIONINE SYNTHASE; METHOTREXATE; NICOTINIC ACID; PHENYTOIN; THEOPHYLLINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; HUMAN; HYPERHOMOCYSTEINEMIA; REVIEW; VASCULAR ENDOTHELIUM; VITAMIN SUPPLEMENTATION;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ANIMALS; ARTERIOSCLEROSIS; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MODELS, BIOLOGICAL; VITAMIN B 12;

EID: 0035131105     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Homocysteine and fibrinolysis in acute obstructive coronary events
2. Vitamin B6 normalizes the altered sulfur amino acid status of rats fed diets containing pharmacological levels of niacin without reducing niacinos high hypolipidemic effects
3. Heterozygosity for homocysteinuria in premature peripheral and cerebral occlusive arterial disease
4. Hyperhomocysteinemies in end-stage renal disease: Prevalence, etiology and potential relationship to atherosclerotic outcomes
5. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland
6. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease
7. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy
8. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms and B vitamins: The atherosclerosis risk in communities (ARIC) study
9. Plasmahomocystein as a risk factor of vascular disease. The European concerted action project
10. High homocysteine, low folic acid and low vitamin B6 concentrations: Prevalent risk factors for vascular disease in heart transplant recipients
11. The oxidant stress of hyperhomocysteinemia
12. Lowering blood homocysteine with folic acid based supplements meta-analysis of randomised trials
13. Homocysteine, diet and cardiovascular diseases: A statement for healthcare professionals from the Nutrion Committee, American Heart Association
14. Vascular pathology of homocysteinemia: Implications for the pathogenesis of atherosclerosis
15. Plasma Homocysteine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease
16. Vitamins and progression of atherosclerosis in hyper-homo-cysteinemia
17. Plasmahomocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
18. Homocystein and cardiovascular disease
19. Hyperhomocysteinemia-induced vascular damage in the minipig. Captopril-hydrochlorothiazide combination prevents elastic alterations
20. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen
21. Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilatation in humans
22. Promotion of vascular muscle cell growth by homocysteine: A link to atherosclerosis
23. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological dosis of folate
24. A second genetic polymorphism in methylentetrahydra-folatreductase (MTHFR) associated with decreased enzyme activity
25. The pathogenesis of coronary artery disease. A possible role for methionine metabolism
26. Folic acid improves arterial endothelial function in adults with hyperhomocysteinemia